Horizon Pharma's inflammatory eye drug aces phase 3, poised for midyear BLA - FierceBiotech https://t.co/5Tz39jmHsz
— IDRO (@IDROOhio) February 28, 2019
from Twitter https://twitter.com/IDROOhio
February 28, 2019 at 12:24PM
Thursday, February 28, 2019
Horizon Pharma's inflammatory eye drug aces phase 3, poised for midyear BLA - FierceBiotech https://t.co/5Tz39jmHsz
from Twitter https://twitter.com/IDROOhio
February 28, 2019 at 12:24PM
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment